All Type of News
SK Chemicals and Sanofi Pasteur sign license agreement of ‘cell culture technology’The SK Chemicals’ technological level has once been recognized by the world as the company exported its vaccine manufacturing technology to a global pharmaceutical company.
SK ... |
LegoChem Bio’s Phase II clinical trial of ‘Super Antibody’ designated for accelerated approval by FDA
LegoChem Biosciences(LegoChem Bio) officially announced that Delpazloid(LCB01-0371), a Phase II clinical trial pipeline, was designated as a medicine for the Fast Track process by the U.S. Food and Drug Administration...
High chance for the next deliberative committee to be held after KPA’s regular general meeting
The people are paying attention to when they will resume the discussion of adjusting the emergency household medicine list, which has been suspended for more than 2 months.
The anticipation is followed because the Ko...
MOHW, “MFDS has been very cooperative in legislating acts for cutting-edge biologics and regenerative medicine”
As understanding the purpose of promoting industries of cutting-edge biologics and regenerative medicines, the Ministry of Health and Welfare(MOHW) announced to cooperate with legislating regulations related to them.
...
Spread of words about prosecution investigating rebates either February and March
The pharmaceutical industry has started to concern about rebate inspections once again. This is because the concern is connected to a personnel reshuffle at the Seoul Western District(SWD) Prosecutors’ Office which ha...
Celltrion Group to decide final location to construct Factory 3 in another countryCelltrion Chairman Jung-Jin Seo released its next-gen pipelines and global market strategies that were planned to carry out by 2030 at the ‘2018 Celltrion Healthcare Internation... |
“It is inadequate for government to take expenses for return of mis/unused medicines”
In response to the Korea Pharmaceutical Association’s(KPA) opinion to obligate return of mis/unused medicines, the Ministry of Health and Welfare(MOHW) answered that it was inadequate.
The MOHW revealed the ‘Stance t...
Conflicts between medical association and government over entirely switching uninsured medical services to insured
Over a discussion about the whole change of uninsured medical services to insured, the government and the Korea Medical Association(KMA) have had conflicts.
The Ministry of Health and Welfare(MOHW) expressed disappoi...
Hanmi CEO Sae-Chang Kwon, “We applied FDA approval for Rolontis and Olita’s Phase III clinical trial”Hanmi Pharm(CEO Sae-Chang Kwon) has set the ‘Hanmi Innovative Management to Become Pharmaceutical Power’ ’as their new year’s resolution.
“During my more than 20-year career at... |
MFDS revises drug approval/assessment guidelines to meet the ICH standards
In order to support pharmaceutical companies’ development of medicines and advance regulations in the drug field, the Ministry of Food and Drug Safety(MFDS) will revise the approval/assessment guidelines at the intern...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
